Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Biol Regul Homeost Agents ; 34(5): 1689-1697, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33107270

RESUMEN

Increased intestinal permeability due to barrier dysfunction is supposed to cause several gastrointestinal diseases. We have previously demonstrated that a single ß-carotene (BC) dose protects against increase in anaphylactic response in ß-lactoglobulin (BLG)-sensitized mice with no effect on the epithelial permeability and weak recovery of villi length. Utilizing the same murine ex vivo intestinal model, the aim of this study was to investigate the effect of different BC doses on BLG-mediated intestinal epithelial barrier disturbances. Jejunum was harvested from BLG-sensitized mice pretreated with either one of three different doses of BC (5, 10 and 20 mg/ kg body weight) and mounted on Ussing Chambers. Transepithelial electrical resistance (TER) and short-circuit current (Isc) were recorded as indicators of intestinal epithelial barrier function. Histopathological analysis of the intestine was carried out for the control and experimental mice. TNF-α and IL-6 levels were determined in serum using ELISA, and the analysis of antioxidant activity was performed for reduced glutathione (GSH) and thiobarbituric acid reactive substances (TBARS). BC was capable of enhancing the intestinal barrier function, as indicated by the increased TER and the decreased Isc. Intestinal damage characterized by the shortening of villi and infiltration of intestinal lymphocytes was significantly reversed by BC pretreatment. Such effects of BC were accompanied by a reduction in the levels of IL-6 and TBARS and an increase of GSH. TNF-α levels were reduced only at the lowest BC dose. These findings may encourage the use of BC-based therapies for controlling the breakdown of the intestinal barrier in vivo.


Asunto(s)
Antioxidantes/fisiología , Citocinas/fisiología , Mucosa Intestinal/fisiopatología , beta Caroteno/uso terapéutico , Animales , Glutatión , Lactoglobulinas , Ratones , Permeabilidad , Sustancias Reactivas al Ácido Tiobarbitúrico
2.
Ann Cardiol Angeiol (Paris) ; 65(3): 208-13, 2016 Jun.
Artículo en Francés | MEDLINE | ID: mdl-27209492

RESUMEN

AIM OF THE STUDY: The search of new anti-obesogenic treatments based on medicinal plants without or with minimal side effects is a challenge. In this context, the present study was conducted to evaluate the anti-obesogenic effect of apple cider vinegar (ACV) in Wistar rats subjected to a high fat diet. MATERIALS AND METHODS: Eighteen male Wistar rats (140±5g) were divided into 3 three equal groups. A witness group submitted to standard laboratory diet and two groups subjected to a high fat diet (cafeteria diet); one receives a daily gavage of apple cider vinegar (7mL/kg/d) for 30 days. Throughout the experiment monitoring the nutritional assessment, anthropometric and biochemical parameters is achieved. RESULTS: In the RCV vs RC group, we observed a highly significant decrease (P<0.001) in body weight and food intake. On the other hand, the VCP decreases very significantly different anthropometric parameters: BMI (P<0.01), chest circumference and abdominal circumference (P<0.001), decreases serum glucose levels (26.83%) and improves the serum lipid profile by reducing plasma levels of total cholesterol (34.29%), TG (51.06%), LDL-c (59.15%), VLDL (50%) and the total lipid (45.15%), and increasing HDL-c (39.39%), thus offering protection against oatherogenic risk (61.62%). CONCLUSION: This preliminary study indicates that the metabolic disorders caused by high fat diet (cafeteria) are thwarted by taking apple cider vinegar which proves to have a satiating effect, antihyperlipidemic and hypoglycemic effects, and seems prevent the atherogenic risk.


Asunto(s)
Ácido Acético/uso terapéutico , Antioxidantes/uso terapéutico , Peso Corporal/efectos de los fármacos , Malus , Obesidad/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Ácido Acético/farmacología , Animales , Antioxidantes/farmacología , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Masculino , Ratas , Ratas Wistar , Resultado del Tratamiento
3.
J Food Prot ; 71(6): 1270-2, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18592759

RESUMEN

This study evaluated the effects of gamma-radiation on the antigenic properties of beta-lactoglobulin in cow's milk. Liquid and lyophilized samples of cow's milk and whey were irradiated with gamma-cells (60Co) at dose levels of 3, 5, and 10 kGy, at room temperature in the presence of air. Effects of treatment on proteins were monitored by Lowry's method, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and enzyme-linked immunosorbent assay. Radiation did not affect the molecular-weight distributions of proteins, but it did reduce their solubility. Furthermore, results showed that irradiation at 10 kGy increased the recognition of milk and whey powders by anti-beta-lactoglobulin (beta-Lg) rabbit immunoglobulin G, with the other samples remaining antigenically stable. These results indicate that gamma-rays do not reduce cow's milk beta-lactoglobulin antigenicity.


Asunto(s)
Irradiación de Alimentos , Rayos gamma , Lactoglobulinas/inmunología , Lactoglobulinas/efectos de la radiación , Hipersensibilidad a la Leche/prevención & control , Leche , Animales , Bovinos , Relación Dosis-Respuesta en la Radiación , Electroforesis en Gel de Poliacrilamida/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina G/efectos de la radiación , Leche/inmunología , Leche/efectos de la radiación , Solubilidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...